Summary
An applicant, representing himself, was denied a security clearance under Guideline H (Drug Involvement). The denial stemmed from his admitted marijuana use between 2007 and 2015, which notably included periods after he had already obtained a security clearance in 2013.
The appeal board affirmed the denial, concluding that the applicant's drug use negatively impacted his security clearance worthiness. This decision was made despite the applicant's assertions of infrequent use and his stated intent to abstain from future drug use.
Specifically, the denial was based on the applicant's admission of using marijuana while holding a security clearance. The judge determined that the applicant's promise to abstain was undermined by his continued drug use post-clearance, and that his drug use was not infrequent, thereby reflecting negatively on his overall security clearance worthiness.
Conditions Referenced
- HraisedDrug Involvement
- H.26(a)rejectedInfrequency of UseThe judge concluded that the applicant's drug use was not infrequent.
- H.26(b)rejectedAcknowledgment and Actions TakenThe applicant's promise to abstain was not sufficient to mitigate the concerns.
Key Rule Quoted
“The general standard is that a clearance may be granted only when ‘clearly consistent with the interests of the national security.’”
Procedural Posture
- SOR issuedOct 31, 2016
- Answer filed—
- Hearing heldMar 30, 2018
- Decision dateJun 22, 2018
Cite For
- Affirmation of Adverse Decision Due to Drug Involvement Under Guideline H
- Harmless Error Doctrine in the Context of Security Clearance Decisions
- Evaluation of Mitigating Conditions Related to Drug Use